378
Views
0
CrossRef citations to date
0
Altmetric
PEER-REVIEWED CORRESPONDENCE

Can drug-induced aseptic meningitis account for some cases of eosinophilic meningitis/meningoencephalitis in dogs?

, ORCID Icon, ORCID Icon &
Pages 184-185 | Received 21 Jul 2021, Accepted 30 Sep 2021, Published online: 25 Oct 2021

References

  • Ashwath M, Katner H. Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib. Postgraduate Medical Journal 79, 295–6, 2003
  • Bihan K, Weiss N, Théophile H, Funck-Brentano C, Lebrun-Vignes B. Drug-induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis. British Journal of Clinical Pharmacology 85, 2540–6, 2019
  • Cardy TJA, Cornelis I. Clinical presentation and magnetic resonance imaging findings in 11 dogs with eosinophilic meningoencephalitis of unknown aetiology. Journal of Small Animal Practice 59, 422–31, 2018
  • Cascella C, Nausheen S, Cunha BA. A differential diagnosis of drug-induced aseptic meningitis. Infections in Medicine 25, 331–4, 2008
  • Kepa L, Oczko-Grzesik B, Stolarz W, Sobala-Szczygiel B. Drug-induced aseptic meningitis in suspected central nervous system infections. Journal of Clinical Neuroscience 12, 562–4, 2005
  • Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Archives of Internal Medicine 159, 1185–94, 1999
  • Quinn JP, Weinstein RA, Caplan LR. Eosinophilic meningitis and ibuprofen therapy. Neurology 34, 108–9, 1984
  • Williams JH, Koster LS, Naidoo V, Odendaal L, Van Veenhuysen A, de Wit M, van Wilpe E. Review of idiopathic eosinophilic meningitis in dogs and cats, with a detailed description of two recent cases in dogs. Journal of the South African Veterinary Association 79, 194–204, 2008
  • Windsor RC, Sturges BK, Vernau KM, Vernau W. Cerebrospinal fluid eosinophilia in dogs. Journal of Veterinary Internal Medicine 23, 275–81, 2009
  • Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P. Drug-induced aseptic meningitis: a mini-review. Fundamental & Clinical Pharmacology 32, 252–60, 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.